We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WULF icon
3926
TeraWulf
WULF
$8.67B
$14K ﹤0.01%
14,989
+2,025
+16% +$1.51K
XERS icon
3927
Xeris Biopharma Holdings
XERS
$1.57B
$14K ﹤0.01%
8,961
-9,906
-53% -$12.4K
VOXX
3928
DELISTED
VOXX International Corporation Class A
VOXX
$14K ﹤0.01%
1,145
-18,179
-94% -$198K
MTTR
3929
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$14K ﹤0.01%
5,261
+2,744
+109% +$8.38K
CSLM
3930
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$14K ﹤0.01%
1,355
+1,349
+22,483% +$13.9K
PRLH
3931
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$14K ﹤0.01%
1,331
+1,061
+393% +$11K
SCX
3932
DELISTED
The L.S. Starrett Company
SCX
$14K ﹤0.01%
1,247
-157
-11% -$1.53K
TAST
3933
DELISTED
Carrols Restaurant Group, Inc.
TAST
$14K ﹤0.01%
6,349
-16,932
-73% -$34.4K
GRCL
3934
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$14K ﹤0.01%
7,665
-5,860
-43% -$12.3K
NM
3935
DELISTED
Navios Maritime Holdings Inc.
NM
$14K ﹤0.01%
7,510
+6,910
+1,152% +$14.4K
HCCI
3936
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$14K ﹤0.01%
385
-437
-53% -$15.8K
ACGN
3937
DELISTED
Aceragen Inc
ACGN
$14K ﹤0.01%
6,155
+4,858
+375% +$25.4K
MTEM
3938
DELISTED
Molecular Templates, Inc.
MTEM
$14K ﹤0.01%
2,384
+772
+48% +$5.21K
CVT
3939
DELISTED
Cvent Holding Corp. Common Stock
CVT
$14K ﹤0.01%
1,646
+210
+15% +$1.51K
WMC
3940
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$14K ﹤0.01%
1,544
+861
+126% +$8.46K
EMKR
3941
DELISTED
Emcore Corp
EMKR
$14K ﹤0.01%
1,181
-462
-28% -$5.64K
IIVI
3942
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
$14K ﹤0.01%
82
+81
+8,100% +$14.6K
ACHR icon
3943
Archer Aviation
ACHR
$5.1B
$13K ﹤0.01%
4,684
-88
-2% -$238
ADAP
3944
DELISTED
Adaptimmune Therapeutics
ADAP
$13K ﹤0.01%
12,272
+4,284
+54% +$6.64K
AKBA icon
3945
Akebia Therapeutics
AKBA
$242M
$13K ﹤0.01%
22,896
+5,685
+33% +$4.34K
ARLO icon
3946
Arlo Technologies
ARLO
$1.54B
$13K ﹤0.01%
2,138
+1,147
+116% +$5.08K
ASTC icon
3947
Astrotech Corp
ASTC
$16.9M
$13K ﹤0.01%
1,133
-1,451
-56% -$17.1K
ATRO icon
3948
Astronics
ATRO
$4.61B
$13K ﹤0.01%
1,135
-28,025
-96% -$313K
BFST icon
3949
Business First Bancshares
BFST
$1.05B
$13K ﹤0.01%
754
+221
+41% +$4.4K
BH.A icon
3950
Biglari Holdings Class A
BH.A
$1.2B
$13K ﹤0.01%
16
-3
-16% -$2.45K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.